Contact Us | Donate | Advertise Follow us on TwitterFollow us on facebookFollow us on LinkedIn


For the most complete display of articles, please login.

Editor - Christine Willis, AHIP
Managing Editor - Susan Talmage
Full Editorial team - click here
MLA News is updated continually. Most articles are restricted to MLA members and/or to members of specific MLA Sections. For the most complete display of articles, please login.
Submit to the MLA News.
Products, services, and events published in the MLA News do not constitute MLA's endorsement or approval. Opinions expressed in MLA News are the authors' and do not necessarily express those of the association.

December Events

MLA News < Article detail

MLA and AAHSL applaud proposed changes to ClinicalTrials procedures

MLA, the Cancer Libraries Section of MLA, and the Association of Academic Health Sciences Libraries (AAHSL) enthusiastically support efforts by the National Institutes of Health (NIH) to expand the requirements to include all NIH-funded clinical trials. The groups also applaud efforts to expand and clarify the regulations for clinical trials registration and results submission.

The Associations and Cancer Libraries Section have developed comments that support changes outlined in the NIH Proposed Rulemaking for Clinical Trials Registration and Results under the Food and Drug Administration Amendments Act. For example, the rulemaking would expand the reporting requirements to include studies that have been closed due to adverse events, difficulties in research design, and for other reasons. Expanding the requirements to include all NIH clinical trials will have many benefits for users of the database who need access to cutting-edge information.

The groups also provided comments in support of the draft NIH Policy on Dissemination of NIH-funded Clinical Trials Information. The draft policy takes steps to enhance the transparency of clinical trial results and provides patients with more information to make health care decisions, including critical information about the safety of products and treatment options. It also provides clinicians with access to results information such as efficacy, adverse effects, and safety.

If no content displays, it may be because the access to this article is member-only. Please login below, and then use the back page control to get back from the home page to the page displaying the article.